首页> BMC neurology> Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis.

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis.

导出 OA

翻译打印收藏纠错

第一作者： Hong,Deng

第一单位： Department of Neurology, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, 430030, China.

作者： Hong,Deng ^[1] ; Gai-Gai,Li ^[2] ; Hao,Nie ^[1] ; Yang-Yang,Feng ^[1] ; Guang-Yu,Guo ^[1] ; Wen-Liang,Guo ^[1] ; Zhou-Ping,Tang ^[3]

作者单位： Department of Neurology, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, 430030, China. ^[1] Department of Neurology, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, 430030, China. lgghuster@163.com. ^[2] Department of Neurology, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, 430030, China. ddjtzp@163.com. ^[3]

关键词 Calcitonin gene-related peptide monoclonal antibody Efficacy Episodic migraine Meta-analysis Safety

医学主题词抗体, 单克隆(Antibodies, Monoclonal);降钙素基因相关肽(Calcitonin Gene-Related Peptide);人类(Humans);偏头痛(Migraine Disorders);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome)

DOI 10.1186/s12883-020-01633-3

PMID 32061264

发布时间 2020-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交